Cite
HARVARD Citation
Ashley, D. et al. (n.d.). Accepting risk in the acceleration of drug development for rare cancers. Lancet oncology. 16 (4), pp. e190-e194. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ashley, D. et al. (n.d.). Accepting risk in the acceleration of drug development for rare cancers. Lancet oncology. 16 (4), pp. e190-e194. [Online].